top of page


ASCPT 2025 Annual Meeting
We're headed to the ASCPT 2025 Annual Meeting! Schedule a time to chat with us at the event.
20 minutes ago


Advancing Drug Development with Non-Liquid Matrix Bioanalysis
Non-liquid matrices are the future of bioanalysis, and Veloxity Labs is leading the charge. Read the report.
4 hours ago


Navigating the 2025 FDA Biomarker Guidance: Key Insights for Successful Validation
The 2025 FDA Biomarker Guidance is finally here, but it’s not without its gaps. Read our report for a breakdown of what’s new, what’s missing, and what it means for your biomarker strategy.
May 1


NorCal SOT Spring Symposium 2025
We’re headed to NorCal SOT Spring Symposium! Veloxity Labs is a proud sponsor—come see how we’re moving at the speed of bioanalysis.
Apr 30


Veloxity Labs Reports Strong Q1 2025 Growth Driven by Founder-Led Strategy and Team-Centric Equity Model
Veloxity Labs announced exceptional year-over-year growth for Q1 2025, reflecting the company’s unique founder-funded, founder-operated model, culture of shared success and an unwavering commitment to operational excellence.
Apr 30


REPORT: Overview - The Value of QAU Audits Using Automated Workflow Data
Check out this QAU audits report to learn more about how our systems and processes allow us to proactively address any challenges, collaborate with principal investigators (PIs) and continuously refine our workflow to drive better outcomes for you!
Apr 29


REPORT: A Side-by-Side Look at Traditional vs. Integrated PK/TK and Bioanalytical Workflows
Read this report for a detailed comparison between conventional pharmacokinetic/toxicokinetic (PK/TK) workflows and a modern, fully integrated approach.
Apr 22
Sample Coordinator
Veloxity Labs is seeking a Sample Coordinator to join their team. See if you're a fit!
Apr 17
Associate Scientist I/II
Veloxity Labs is seeking an Associate Scientist I or II to join their team. See if you're a fit!
Apr 17


REPORT: VELOCITY VS. SPEED - The Veloxity Labs Difference
Download this report to learn how we leverage velocity to achieve optimal outcomes, maintain the highest standards and more.
Apr 9


Veloxity Labs at WRIB 2025 – Moving at the Speed of Bioanalysis
Stop by Booth #54 at WRIB 2025 to discover how we can support your preclinical & clinical studies with speed, precision and compliance.
Mar 24


REPORT: Pushing the Limits of Bioanalysis - Overcoming Selectivity Challenges in Medical Device Studies
Download this report to gain valuable insights into the complexities of bioanalysis in medical device studies and more.
Mar 24


PBSS Biotech Seminar Luncheon
Veloxity Labs is proud to sponsor the upcoming PBSS Biotech Seminar Luncheon on April 1 at the Seattle Asian Art Museum.
Mar 21


VIDEO: Adopting the ICH M10 Guidance for Animal Health Bioanalysis with Chris Tudan, Director of Biochemistry and Quality Assurance
In this video, Chris Tudan, PhD, breaks down the recent breakthroughs in adopting the ICH M10 guidance for animal health bioanalysis.
Feb 27


SPEED MEETS ACCURACY: The Competitive Edge of Fast Turnaround Times and Precise Data in Bioanalysis
Download our report to explore the importance of bioanalytical turnaround times, why they matter to your project timelines and more.
Feb 24


BROCHURE: Accelerating bioanalysis. Your data, on time.
Read our brochure to find out why clients turn to our bioanalytical CRO for fast start-up times, a foundation of quality, and more.
Feb 19


Bioanalytical CRO, Veloxity Labs, Partners with Aplos Analytics to Transform Pharmacokinetic and Toxicokinetic Analysis
The partnership with Aplos promises groundbreaking enhancements to pharmacokinetic (PK) and toxicokinetic (TK) analysis for lightning-fast,
Feb 12


BROCHURE: Integrated Bioanalysis and PK/TK Analysis for Synchronized Data Delivery
Link your bioanalysis with noncompartmental analysis (NCA) for comprehensive insights – all at once, without the wait!
Feb 11


Backlog: A Double-Edged Sword in Bioanalytical CRO M&A?
Learn how backlog can signal growth—or reveal risks like delays & client dissatisfaction.
Feb 4


The Pros and Cons of Backlog for Bioanalytical CROs: A Client-Driven Approach
Our client-driven backlog approach ensures faster project start times and streamlined operations. Discover why it’s a game-changer.
Jan 17
Sign up to get new blogs
bottom of page